TORL-2-307-ADC

· TORL Biotherapeutics, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TORL-2-307-ADC, covering 2026-01-13 to 2026-01-13. Get the full timeline:

Most recent: Clinical Trial Update: First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer [Phase 1]